8-K: Broadway Financial Faces Nasdaq Delisting Warning Over Late Q3 Filing
Current Report
Broadway Financial Corporation received a notice from Nasdaq regarding non-compliance with listing rules due to the late filing of its Q3 2025 quarterly report.
Summary
- Broadway Financial Corporation (BYFC) received a notice from Nasdaq on November 20, 2025, for non-compliance with Listing Rule 5250(c)(1) due to the late filing of its Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 (Q3 Form 10-Q).
- The delay is attributed to the ongoing evaluation of sold loan participation accounting in accordance with Accounting Standards Codification Topic 860 and its impact on consolidated financial statements.
- Nasdaq has given the Company until December 8, 2025, to submit an updated plan to regain compliance.
- The notice has no immediate effect on the listing or trading of BYFC's common stock on The Nasdaq Capital Market.
- Any additional extension granted by Nasdaq for delinquent filings, including the Q3 Form 10-Q, will be limited to the previously established deadline of February 16, 2026, which was initially for the Q2 Form 10-Q.
Sentiment
Score: 3
Explanation: The filing indicates a significant compliance issue with Nasdaq due to a late financial report, stemming from complex accounting challenges. While there's no immediate delisting, the recurring nature of the delay and the underlying accounting complexity are negative indicators, raising concerns about financial transparency and operational efficiency.
Positives
- The Nasdaq notice has no immediate effect on the listing or trading of the Company's common stock.
- The Company expects to regain compliance in the near future and plans to submit an updated compliance plan by December 8, 2025.
Negatives
- The Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to the late filing of its Q3 Form 10-Q.
- This is a recurring issue, as the Company previously received an extension for its Q2 Form 10-Q, and the new Q3 filing must also meet the February 16, 2026 deadline.
- The delay stems from complex accounting evaluation related to sold loan participation, indicating potential internal control or financial reporting challenges.
Risks
- Nasdaq may reject the Company's updated plan to regain compliance.
- There is a risk of a material delay in the Company's financial reporting beyond the February 16, 2026 deadline.
- Further delays in filing SEC reports could impact the listing or trading of the Company's common stock.
- The underlying accounting issue (evaluation of sold loan participation accounting) could reveal significant financial statement adjustments.
Future Outlook
The Company expects to provide an updated compliance plan to Nasdaq by December 8, 2025, and intends to file the Q3 Form 10-Q as promptly as reasonably practicable, aiming to regain compliance by the February 16, 2026 extension deadline.
Management Comments
- The Company currently expects to regain compliance in the near future.
- The Company expects to provide the updated compliance plan to Nasdaq and to file the Q3 Form 10-Q as promptly as reasonably practicable.
Industry Context
Timely and accurate financial reporting is a fundamental requirement for publicly traded companies, especially in the highly regulated banking sector. Delays, particularly those stemming from complex accounting evaluations, can signal potential internal control weaknesses or significant financial adjustments, which regulators and investors scrutinize closely. This situation places Broadway Financial under increased regulatory pressure, similar to other financial institutions facing heightened scrutiny over accounting practices.
Comparison to Industry Standards
- Timely filing of quarterly reports is a standard expectation for all publicly traded companies, particularly within the financial services industry where transparency and regulatory compliance are paramount.
- Companies like JPMorgan Chase, Bank of America, or Wells Fargo consistently meet these deadlines, and any deviation by a smaller institution like Broadway Financial Corporation immediately raises concerns about operational efficiency, internal controls, and financial health.
- The delay due to 'sold loan participation accounting' suggests a complex issue that could be indicative of challenges in adhering to GAAP (Generally Accepted Accounting Principles) or specific ASC topics, which is a red flag compared to industry best practices for financial reporting accuracy and timeliness.
Stakeholder Impact
- Shareholders face increased risk of potential delisting if compliance is not regained, and uncertainty regarding the Company's financial health due to delayed reporting.
- Investors/Analysts lack timely financial information to make informed investment decisions, leading to reduced confidence and potential stock price volatility.
- Regulators will increase scrutiny due to non-compliance with reporting requirements from Nasdaq and the SEC.
Next Steps
- Submit an updated plan to Nasdaq to regain compliance with Rule 5250(c)(1) by December 8, 2025.
- File the Q3 Form 10-Q as promptly as reasonably practicable.
- Regain compliance with all delinquent filings by the Extension Deadline of February 16, 2026.
Key Dates
| Date | Description |
|---|---|
| 2025-08-22 | Date of Current Report on Form 8-K disclosing an extension from Nasdaq for the Q2 Form 10-Q. |
| 2025-09-30 | End of the third quarter for which the Form 10-Q was not timely filed. |
| 2025-11-14 | Date of Form 12b-25 filed with the SEC, disclosing inability to timely file the Q3 Form 10-Q. |
| 2025-11-20 | Date Broadway Financial Corporation received written notice from Nasdaq regarding non-compliance. |
| 2025-11-25 | Date of the press release issued by the Company regarding the Nasdaq notice and the filing date of this 8-K. |
| 2025-12-08 | Deadline for the Company to submit an updated plan to Nasdaq to regain compliance. |
| 2026-02-16 | Extension Deadline granted by Nasdaq for filing delinquent reports, including the Q2 and Q3 Form 10-Qs. |
Recommendation
sellThe recurring nature of late financial filings, now impacting two consecutive quarters (Q2 and Q3 2025), signals persistent issues with internal controls and financial reporting processes. The specific reason for the delay—complex accounting for 'sold loan participation'—suggests potential material adjustments or difficulties in adhering to accounting standards, which could negatively impact the company's reported financial health. While there's no immediate delisting, the risk of Nasdaq rejecting the compliance plan or further delays beyond the February 16, 2026 deadline is significant. This ongoing uncertainty and lack of timely financial transparency make the stock a high-risk investment, warranting a 'sell' recommendation until the company demonstrates consistent compliance and resolves its underlying accounting challenges.
Keywords
Broadway Financial Corporation, BYFC, Nasdaq, delisting notice, Form 10-Q, late filing, financial reporting, compliance, SEC filing, accounting standards, loan participation, City First Bank
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.